Drug discovery platform Exscientia sets terms for $275 million US IPO

Robert Marcus
Sep 27, 2021

Related news

Nov 3
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Pandemic has caused perfect storm for MedTech

Jun 2
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The Heart of AI

Dec 20
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Analysts forecast LS tech and business trend of 2022

Aug 11
,
0221
AI
Cleantech
Healthcare
Investment
Life Science
Press

Major venture capital investment in European life sciences will fuel occupier market

Sep 21
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

UK life science attracts £850m deal

Dec 20
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI Innovation Incubator spearheaded for the sciences

Apr 11
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Ronald Cohen: “Mesurons l’impact comme on mesure les profits”

Oct 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

Sep 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Prospection Secures $45 million to Accelerate Growth of its Powerful Healthcare Insights Technology

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Intelligence Artificielle : l'UM6P signe un partenariat avec la start-up ALPHA10X

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding